About Me
As a Market Access Value Consultant, I take pleasure in creating market access strategies that provide additional value to all stakeholders. My comprehensive approach ensures that patients have access to reimbursable medicines for optimal treatment throughout their lifecycle. Utilizing agile methodologies and contemporary technologies, I enhance the current market and create new business prospects. I am dedicated to assisting businesses in flourishing and succeeding within the dynamic market access landscape of today.
MARKET ACCESS EXPERIENCE
2009
ViiV Healthcare was founded through a collaboration between GSK, Pfizer and Shionogi. Member of the team In-licensing HIV pharmaceuticals Pfizer
2010-2013
Member of both international and national teams prepared for the challenge of obtaining marketing authorization for new drugs.
Implementing ViiV Healthcare within the German healthcare system
2014-2020
ViiV Healthcare: Market Access preparation 4 approvals HIV drugs, managing LOE and tenders, Implementation HIV drugs reimbursement system
2020-2023
Establishing market access department Dr.Falk Pharma / Managing tender business / preparation approval HTA submission drug rare diseases
2023
Mundipharma GmbH: Patient & Value Director Lead HTA admission approval orphan drug
2024
Healthcare Value Consultant – Independent freelancer